Evaluation Of Resectability Of Pancreatic Cancer Using Low KVp CT

Study Overview

Evaluation of Resectability of Pancreatic Cancer Using Low kVp CT

The aim of this study is to investigate usefulness of low kVp high mAs computed tomography in evaluation of pancreatic cancer resectability.

N/A

Diagnoses Disease

DIAGNOSTIC_TEST: contrast enhanced computed tomography

SNUH-2019-0140

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates	Results Reporting Dates	Study Record Updates
First Submitted 2019-03-06	Results First Submitted N/A	Last Update Submitted that met QC Criteria 2021-03-19
First Submitted that Met QC Criteria 2019-03-27	Results First Submitted that Met QC Criteria N/A	Last Update Posted (ACTUAL) 2021-03-22
First Posted (ACTUAL) 2019-03-29	Results First Posted N/A	Last Verified 2021-03

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Diagnostic

Allocation:
Na

Interventional Model:
Single Group

Masking:
None

Arms and Interventions

Participant Group/Arm	Intervention/Treatment
EXPERIMENTAL: low kVp high mAs CT group doing pancreatic CT with 80 kVp tube current with more than 500 mA tube current for the evaluation of pancreatic cancer resectability	DIAGNOSTIC_TEST: contrast enhanced computed tomography pancreatic protocol CT with 80kVp tube voltage and more than 500mA tube current acquire late arterial phase and portal venous phase using volus tracking method

Participant Group/Arm

Intervention/Treatment

EXPERIMENTAL: low kVp high mAs CT group

doing pancreatic CT with 80 kVp tube current with more than 500 mA tube current for the evaluation of pancreatic cancer resectability

DIAGNOSTIC_TEST: contrast enhanced computed tomography

pancreatic protocol CT with 80kVp tube voltage and more than 500mA tube current acquire late arterial phase and portal venous phase using volus tracking method

Primary Outcome Measures	Measure Description	Time Frame
accuracy of low kVp CT to assess R0 resection of pancreatic cancer	Pancreastic cancer resectability	2 weeks after surgery

Secondary Outcome Measures	Measure Description	Time Frame

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
20 Years

Accepts Healthy Volunteers:

1. age between 20 year-old and 85 year-old 2. patient with pancreatic cancer detected on standard CT scan using 120 kVp that obtained within one month 3. consider surgical resection for pancreatic cancer treatment 4. patients who can undergo contrast enhanced CT scan

1. history of severe adverse reaction to iodine contrast 2. less than 60 of estimated GFR

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

PRINCIPAL_INVESTIGATOR: Jeong Min Lee, MD, Seoul National University Hospital

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available

Learn

Resources

PatientS

Caregivers

Clinical Trial Record